Gastric inhibitory polypeptide and effects of glycation on glucose transport and metabolism in isolated mouse abdominal muscle

Journal of Endocrinology

Volumn 156, Issue 2, 1998, Pages 237-243

  O'Harte, F P M ^a   Gray, A M ^a   Flatt, P R ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGLUCOSE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE; GLYCOGEN; LACTIC ACID;

ABDOMINAL WALL MUSCULATURE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLYCATION; GLYCOGEN SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL TRANSPORT; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE; GLYCOGEN; GLYCOSYLATION; INSULIN; LACTIC ACID; MALE; MICE; MUSCLE, SKELETAL; OXIDATION-REDUCTION; STIMULATION, CHEMICAL;

EID: 0031930530     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1560237     Document Type: Article

References (40)

1. Abdel-Wahab YHA, O'Harte FPM, Ratcliff H, McClenaghan NH, Barnett CR & Flatt PR 1996a Glycation of insulin in the islets of Langerhans of normal and diabetic animals. Diabetes 45 1489-1496.
2. Abdel-Wahab YHA, O'Harte FPM, Gray AM & Flatt PR 1996b Glycation of GLP-1(7-36)amide but not GIP reduces its insulinotropic action in vitro. Diabetologia 39 A23.
3. Abdel-Wahab YHA, O'Harte FPM, Barnett CR & Flatt PR 1997 Characterization of insulin glycation in insulin-secreting cells maintained in tissue culture. Journal of Endocrinology 152 59-67.
4. Andersen DK, Elahi D, Brown JC, Tobin JD & Andres R 1978 Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels. Journal of Clinical Investigation 62 152-161.
5. Brown JC, Mutt V & Pederson RA 1970 Further purification of a polypeptide demonstrating enterogastrone activity. Journal of Physiology 209 57-64.
6. Cataland S, Crockett SE, Brown JC & Mazzaferri EL 1974 Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man. Journal of Clinical Endocrinology and Metabolism 39 223-228.
7. Delgado E, Luque MA, Alcántara AI, Trapote MA, Clemente F, Galera C, Valverde I & Villanueva-Peñacarrillo ML 1995 Glucagon-like peptide-1 binding to rat skeletal muscle. Peptides 16 225-229.
8. Ebert R, Nuack M & Creutzfeldt W 1991 Effects of exogenous and endogenous gastric inhibitory polypeptide on plasma triglyceride responses in rats. Hormone and Metabolic Research 23 517-521.
9. Eckel RH, Fujimoto WJ & Brunzell JD 1979 Gastric inhibitory polypeptide enhances lipoprotein lipase activity in cultured pre-adipocytes. Diabetes 28 1141-1142.
10. Elahi D, Meneilly GS, Minaker KL, Rowe JW & Andersen DK 1986 Regulation of hepatic glucose production by gastric inhibitory polypeptide in man. In Proceedings of the Sixth International Conference on Gastrointestinal Hormones, Vancouver, BC, p 18. Ottawa: National Research Council of Canadian Research Journals.
11. Fehmann H-C, Göke R & Göke B 1995 Cell and molecular biology of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulin releasing polypeptide. Endocrine Review 16 390-410.
12. Flatt PR, Kwasowski P, Howland RJ & Bailey CJ 1991 Gastric inhibitory polypeptide and insulin responses to orally administered amino acids in genetically obese hyperglycaemic (ob/ob) mice. Journal of Nutrition 121 1123-1128.
13. Flatt PR, Abdel-Wahab YHA, Wilson AM, Barnett CR, O'Harte FPM & Swanston-Flatt SK 1994 Site-specific defects and glucose toxicity in pancreatic B-cell dysfunction of non-insulin dependent diabetes mellitus. In Frontiers of Insulin Secretion and Pancreatic B-cell Research, pp 481-489. Eds PR Flatt & S Lenzen. London: Smith-Gordon & Co. Ltd.
14. Galera C, Clemente F, Alcántara A, Trapote MA, Perea A, López-Delgado MI, Villanueva-Peñacarrillo ML & Valverde I 1996 Inositolphosphoglycans and diacylglycerol are possible mediators of the glycogenic effect of GLP-1(7-36)amide in BC3H-1 myocytes. Cell Biochemistry and Function 14 43-48.
15. Hampton SM, Kwasowski P, Tan K, Morgan LM & Marks V 1983 Effect of pre-treatment of a high fat diet on the gastric inhibitory polypeptide and insulin responses to oral triolein and glucose in rats. Diabetologia 24 278-281.
16. Hartmann H, Ebert R & Creutzfeldt W 1986 Insulin-dependent inhibition of hepatic glycogenolysis by gastric inhibitory polypeptide (GIP) in perfused rat liver. Diabetologia 29 112-114.
17. Hunter SJ, Wiggam MI, Boyd AC, O'Harte FPM, Ennis CN, Gamble R, Sheridan B, Barnett CR, McNulty H, Bell PM & Flatt PR 1996 Glycation of human insulin reduces its biological potency as assessed by euglycaemic clamps in normal man. Diabetic Medicine 13 (Suppl 7) S17 (Abstract).
18. kaplan AM & Vigna SR 1994 Gastric inhibitory polypeptide (GIP) binding sites in rat brain. Peptides 15 297-302.
19. Krarup T, Holst JJ & Larsen KL 1985 Responses and molecular heterogeneity of IR-GIP after intraduodenal glucose and fat. American Journal of Physiology 249 E195-E200.
20. Kwasowski P, Flatt PR, Bailey CJ & Marks V 1985 Effect of fatty acid chain length and saturation on gastric inhibitory peptide release in obese hyperglycaemic (ob/ob) mice. Bioscience Reports 5 701-705.
21. Maletti M, Portha B, Hoa DHB, Carlquist M & Rosselin G 1986 Evidence of functional gastric inhibitory polypeptide (GIP) receptors in human insulinoma. Binding of synthetic human GIP 1-31 and activation of adenylate cyclase. Diabetes 36 1336-1340.
22. Marchand-Brustel YM & Freychet P 1981 Regulation of glycogen synthase activity in the isolated mouse soleus muscle. Effect of insulin, epinephrine, glucose and anti-insulin receptor antibodies. Biochimica et Biophysica Acta 677 13-22.
23. Maxwell V, Shulkes A, Brown JC, Solomon TE, Walsh JH & Grossman MI 1980 Effect of gastric inhibitory polypeptide on pentagastrin-stimulated acid secretion in man. Digestive Diseases and Science 25 113-116.
24. Moens K, Heimberg H, Flamez D, Huypens P, Quartier E, Ling Z, Pipeleers D, Gremlich S, Thorens B & Schuit F 1996 Expression and functional activity of glucagon, glucagon-like peptide 1, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 45 257-261.
25. Morgan LM 1996 The metabolic role of GIP: physiology and pathology. Biochemical Society Transactions 24 585-591.
26. Morgan LM, Flatt PR & Marks V 1988 Nutrient regulation of the entero-insular axis and insulin secretion. Nutrition Research Review 1 79-97.
27. Nauck MA, Bartels E, Orskov C, Ebert R & Creutzfeldt W 1992 Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1(3-36)amide infused at near physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects. Digestion 52 214-221.
28. Oben J, Morgan L, Fletcher J & Marks V 1991 Effect of the entero-pancreatic hormones gastric inhibitory polypeptide and glucagon-like peptide-1(7-36)amide on fatty acid synthesis in explants of rat adipose tissue. Journal of Endocrinology 130 267-272.
29. O'Harte FPM, Höjrup P, Barnett CR & Flatt PR 1996 Identification of the site of glycation of human insulin. Peptides 17 1323-1330.
30. O'Harte FPM, Gray AM, Abdel-Wahab YHA & Flatt PR 1998 Effects of non-glycated and glycated glucagon-like peptide-1(7-36) amide on glucose metabolism in isolated mouse abdominal muscle. Peptides 18 (In Press).
31. Pedersen RA 1994 Gastric inhibitory polypeptide. In Gut Peptides: Biochemistry and Physiology, pp 217-259. Eds JH Walsh & GJ Dockray. New York: Raven Press Ltd.
32. [1-30]OH. Digestion 46 86.
33. Penman E, Wass JAH, Medbank S, Morgan LM, Lewis J, Besser GM & Rees LH 1981 Response of circulating somatostatin to nutritional stimuli in normal subjects. Gastroenterology 81 692-699.
34. Roe JA, Baba ASH, Harper JMM & Buttery PJ 1995 Effects of growth factors and gut regulatory peptides on nutrient uptake in ovine muscle cell cultures. Comparative Biochemistry and Physiology 110 107-114.
35. Schmidt WE, Siegel EG, Ebert R & Creutzfeldt W 1986 N-terminal tyrosine-alanine is required for the insulin releasing activity of glucose-dependent insulinotropic polypeptide. European Journal of Clinical Investigation 16 A9.
36. Suzuki S, Kawai K, Ohashi S, Watanabe Y & Yamashita K 1992 Comparison of the insulinotropic activity of the glucagon-superfamily peptides in rat pancreas perfusion. Hormone and Metabolic Research 24 458-461.
37. Sykes S, Morgan LM, English J & Marks V 1980 Evidence for preferential stimulation of gastric inhibitory polypeptide secretion in the rat by actively transported carbohydrates and their analogues. Journal of Endocrinology 85 201-207.
38. Usdin TB, Mezey E, Button DC, Brownstein MJ & Bonner TI 1993 Gastric inhibitory polypeptide receptor, a member of the secretin vasoactive polypeptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 133 2861-2870.
39. Villanueva-Peñacarrillo ML, Alcantara AL, Clemente F, Delgado E & Valverde I 1994 Potent glycogenic effect of GLP-1(7-36)amide in rat skeletal muscle. Diabetologica 37 1163-1166.
40. Wheeler MB, Gelling RW, McIntosh CHS, Georgioi J, Brown J & Pedersen RA 1995 Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signalling properties. Endocrinology 136 4629-4639.